Fomivirsen

This classification denotes an antisense agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3Z6W3S36X5. European Medicines Agency schedules Fomivirsen sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02253MIG. Fomivirsen sodium generally arises in the molecular formula C204H243N63O114P20S20.20NA. The term FOMIVIRSEN SODIUM is a United States Adopted Name designation. Most nations schedule fomivirsen under HS 29349990 and SITC 51579. As of Q4 2014, FOMIVIRSEN remains the US FDA Preferred Term for this commodity. SMILES: S=P(OC1C(OC(N2CC(C(=O)[NH]C2=O)C)C1)COP(=S)(OC1C(OC(N2CC(C(=O)[NH]C2=O)C)C1)COP(=S)(OC1C(OC(N2CC(C(=O)[NH]C2=O)C)C1)COP(=S)(OC1C(OC(N2C3NC([NH]C(=O)C3NC2)N)C1)COP(=S)(OC1C(OC(N2CCC(NC2=O)N)C1)COP(=S)(OC1CC(OC1CO)N1C2NC([NH]C(=O)C2NC1)N)O)O)O)O)O)(OCC1OC(N2C3NC([NH]C(=O)C3NC2)N)CC1OP(=S)(OCC1OC(N2CCC(NC2=O)N)CC1OP(=S)(OCC1OC(N2CC(C(=O)[NH]C2=O)C)CC1OP(=S)(OCC1OC(N2CCC(NC2=O)N)CC1OP(=S)(OCC1OC(N2CC(C(=O)[NH]C2=O)C)CC1OP(=S)(OCC1OC(N2CC(C(=O)[NH]C2=O)C)CC1OP(=S)(OCC1OC(N2CCC(NC2=O)N)CC1OP(=S)(OCC1OC(N2CC(C(=O)[NH]C2=O)C)CC1OP(=S)(OCC1OC(N2CC(C(=O)[NH]C2=O)C)CC1OP(=S)(OCC1OC(N2CCC(NC2=O)N)CC1OP(=S)(OCC1OC(N2CC(C(=O)[NH]C2=O)C)CC1OP(=S)(OCC1OC(N2CC(C(=O)[NH]C2=O)C)CC1OP(=S)(OCC1OC(N2C3[NH]C(NC(=O)C3NC2)N)CC1OP(=S)(OCC1OC(N2CCC(NC2=O)N)CC1OP(=S)(OCC1OC(N2C3NC([NH]C(=O)C3NC2)N)CC1O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O.